Search results
Results from the WOW.Com Content Network
A French study published in 2024 found that the use of hydroxychloroquine may have been associated with 17,000 deaths in Belgium, Turkey, France, Italy, Spain, and the United States. [61] [62] This study was ultimately retracted on August 22, 2024, after "the Editor-in-Chief found the conclusions of the article to be unreliable".
Chloroquine and its derivative hydroxychloroquine are FDA-approved to treat certain parasitic infections (e.g. malaria) and auto-immune diseases such as lupus and arthritis. Potentially serious side effects from chloroquine or hydroxychloroquine include irregular heartbeats, tinnitus, blurred vision, muscle weakness or "mental changes".
Among those were chloroquine and hydroxychloroquine, which have been successfully used to treat malaria for over fifty years. A small test in France by researcher Didier Raoult had given positive results, although the study was criticized for design flaws, small sample size, and the fact that it was published before peer review. [23]
The medical journal The Lancet on Thursday retracted a large study on the use of hydroxychloroquine to treat COVID-19 because of potential flaws in the research data. Thursday's retraction doesn't ...
A new study suggests hydroxychloroquine, which President Donald Trump has endorsed as a potential treatment for COVID-19, does not benefit coronavirus patients who received it. The National ...
A study that prompted hope for a COVID-19 treatment in the early days of the pandemic has now been formally withdrawn by the scientific journal that published it.. Hydroxychloroquine, an ...
In March 2020, then US President Donald Trump promoted the use of chloroquine and hydroxychloroquine, two related anti-malarial drugs, for treating COVID-19. The FDA later clarified that it has not approved any therapeutics or drugs to treat COVID-19, but that studies were underway to see if chloroquine could be effective in treatment of COVID-19.
Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday ...